Skip to Content

Dexamethasone Sodium Phosphate Injection

Last Updated: December 13, 2018
Status: Current

Products Affected - Description
    • Dexamethasone Sodium Phosphate injection, AuroMedics, 4 mg/mL, 1 mL vial, 25 count, NDC 55150-0237-01
    • Dexamethasone Sodium Phosphate injection, AuroMedics, 4 mg/mL, 30 mL vial, 25 count, NDC 55150-0239-30
    • Dexamethasone Sodium Phosphate injection, AuroMedics, 4 mg/mL, 5 mL vial, 25 count, NDC 55150-0238-05
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL preservative-free single dose vial, 25 count, NDC 63323-0506-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0106-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL single dose vial, 25 count, NDC 63323-0165-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 30 mL multiple dose vial, 1 count, NDC 63323-0165-30
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 1 mL vial, 25 count, NDC 00641-6145-25
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 5 mL vial, 25 count, NDC 00641-6146-25
Reason for the Shortage
    • American Regent is not marketing dexamethasone sodium phosphate injection at this time.
    • AuroMedics has dexamethasone sodium phosphate on intermittent back order.
    • Fresenius Kabi has dexamethasone sodium phosphate presentations available.
    • Mylan Institutional has dexamethasone sodium phosphate available.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 63323-0516-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0165-05
    • Dexamethasone Sodium Phosphate injection, Hikma, 10 mg/mL, 1 mL vial, 25 count, NDC 00641-0367-25
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 10 mg/mL, 10 mL vial, 10 count, NDC 67457-0420-10
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 4 mg/mL, 1 mL vial, 25 count, NDC 67457-0423-12
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 4 mg/mL, 30 mL vial, 25 count, NDC 67457-0421-30
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 4 mg/mL, 5 mL vial, 25 count, NDC 67457-0422-54

Estimated Resupply Dates

    • AuroMedics has dexamethasone sodium phosphate 4 mg/mL 1 mL, 5mL, and 30 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Fresenius Kabi has dexamethasone sodium phosphate 4 mg/mL 1 mL prefilled syringes on back order and the company estimates a release date of 1st quarter 2019. The 10 mg/mL 1 mL preservative-free vials are on back order and the company estimates a release date of late-December 2018. The 4 mg/mL 1 mL and 30 mL vials are on back order and the company estimates a release date of mid-December 2018 for the 1 mL vials and late-December 2018 for the 30 mL vials.
    • Hikma has dexamethasone sodium phosphate 4 mg/mL 1 mL and 5 mL vials on back order and the company cannot estimate a release date.

Updated

Updated December 13, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 18, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide